The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community-Reference-Cited by-同舟云学术

The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community

Published:2021-12 Issue: Volume:77 Page:194-202
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Petrillo Marco^ORCID,Sozzi Giulio^ORCID,Dessole Margherita,Capobianco Giampiero^ORCID,Dessole Salvatore,Madonia Massimo,Cherchi Pier Luigi,Paoletti Anna Maria,Scambia Giovanni,Chiantera Vito

Publisher

Elsevier BV

Subject

Cancer Research

Reference55 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Ovarian cancer statistics, 2018;Torre;CA Cancer J. Clin.,2018

3. Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design;Markman;J. Clin. Oncol.,2004

4. Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin;Markman;J. Clin. Oncol.,1991

5. Surgery for relapsed ovarian cancer: when should it be offered?;Harter;Curr. Oncol. Rep.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen and progesterone receptor expression: Impacts on platinum sensitivity and survival outcomes in high‐grade serous ovarian cancer;Malignancy Spectrum;2024-08-04

2. Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group;Frontiers in Oncology;2024-06-04

3. Clinical characteristics and treatment modalities in women with newly diagnosed advanced high-grade serous epithelial ovarian cancer in Taiwan;Journal of the Formosan Medical Association;2024-03

4. Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study;Journal of Gynecologic Oncology;2024

5. ATR Inhibitors in Platinum-Resistant Ovarian Cancer;Cancers;2022-11-29